Introduction: The Urgent Need for Sustainable Endotoxin Testing

Endotoxin contamination poses a critical safety risk in biologics, vaccines, pharmaceuticals, and medical devices. These toxic molecules, derived from the outer membrane of Gram-negative bacteria, can trigger fever, septic shock, or even fatal immune responses if not carefully controlled. For this reason, endotoxin detection is a mandatory quality control step across the life sciences industry, from injectable drugs and antibiotics to cutting-edge mRNA therapies, plasmid-based products, and cell & gene therapies.

Historically, most manufacturers have relied on the Limulus Amebocyte Lysate (LAL) test, derived from the blood of the horseshoe crab. However, this dependence has raised urgent sustainability concerns. In 2019, the International Union for Conservation of Nature (IUCN) officially listed the Chinese horseshoe crab as an endangered species, highlighting the ecological cost of LAL-based testing.

As the demand for bacterial endotoxin testing grows, the industry urgently needs a sustainable, accurate, and animal-free alternative.

Current Endotoxin Detection Methods and Their Limitations

There are four major methods currently used in pyrogen and endotoxin testing:

1. Rabbit Pyrogen Test (RPT)
• One of the earliest methods, using live rabbits to monitor fever response.
• Limited sensitivity, low throughput, and ethical concerns make it unsuitable for modern large-scale QC testing.
2. Monocyte Activation Test (MAT)
• Human cell-based, designed to mimic innate immune response.
• Valuable for some applications but lacks standardization and is less commonly used in routine QC.
3. Limulus Amebocyte Lysate (LAL) Test
• The current gold standard. Sensitive and widely adopted.
• Major limitations: dependence on wild horseshoe crab populations, interference from β-glucans, and environmental sustainability concerns.
4. Recombinant Factor C (rFC) Test
• A synthetic, animal-free alternative based on recombinant technology.
• Delivers high specificity, precision, and reproducibility, making it the future mainstream method for endotoxin detection.

Why transition to recombinant factor C? Because it eliminates reliance on horseshoe crab blood while offering equal or superior performance compared to LAL reagents.

Hzymes’ Recombinant C Factor Endotoxin Detection Kit: A Next-Gen Solution

Hzymes Biotech has developed the Recombinant C Factor Endotoxin Detection Kit, a sustainable alternative that combines scientific innovation with ecological responsibility.

Principle of Technology

The kit uses gene-recombinant expression of Factor C protein. When the recombinant Factor C binds to endotoxins, it activates a reaction that cleaves a fluorescent substrate, releasing measurable fluorescence. The intensity of fluorescence is directly proportional to endotoxin concentration, enabling highly accurate quantification.

Key Advantages over LAL:

• Animal-free, eco-friendly: Protects endangered horseshoe crabs.
• Superior specificity & precision: Reduces false positives and improves batch-to-batch consistency.
• Regulatory alignment: Comparable to LAL results, compatible with multiple pharmacopeia standards.

Product Performance and Technical Highlights

One-step detection, endpoint fluorescence determination, detection time only 90 minutes.

High sensitivity (0.005EU/mL~5EU/mL), good batch-to-batch and intra-batch consistency, and sample recovery rate meets standards. 

No G factor bypass interference, suitable for endotoxin detection in samples with β-glucan interference, avoiding false positives.

The lyophilized standard can be stored at 4°C for up to 60 days after reconstitution, and the kit can be stably stored for 1 year.

Suitable for different types of sample detection, sample measurements can correspond to LAL reagents, and applicable to multiple microplate readers.

For various types of samples exhibiting abnormal endotoxin recovery, multiple endotoxin masking removal solutions are available. After treatment, spiked recovery rates meet the acceptance criteria, enabling accurate quantification of endotoxin content in the samples.

Solutions for Challenging Samples

Endotoxin recovery can sometimes be abnormal due to sample matrix effects. To address this, Hzymes provides multiple endotoxin masking and removal solutions, ensuring that recovery rates meet pharmacopeia acceptance criteria.

This guarantees accurate endotoxin quantification even in complex samples, including:

• mRNA & plasmid preparations
• Cell and gene therapy products
• Vaccine formulations
• Injectable biologics and antibiotics

Regulatory Compliance and Broad Applications

The kit is designed to support global regulatory compliance, including USP, EP, JP, and ChP guidelines for endotoxin testing.

Key Applications:

• Biological drugs & vaccines
• mRNA and plasmid-based therapies
• Cell & gene therapy
• Injectable pharmaceuticals and antibiotics
• Medical devices & implantable biomaterials

By ensuring robust quality control, Hzymes’ recombinant factor C assay empowers biopharma companies, CROs, and CDMOs to deliver safe, reliable, and compliant products.

Conclusion: Protect Animals, Ensure Safety, Lead Innovation

As the world shifts towards sustainable and ethical practices, animal-free endotoxin detection is no longer just an option — it’s a necessity.

The Hzymes Recombinant C Factor Endotoxin Detection Kit represents the future of bacterial endotoxin testing:

• Protects endangered species by eliminating horseshoe crab dependence.
• Delivers superior accuracy and reproducibility.
• Aligns with global pharmacopeia and regulatory standards.

By adopting recombinant factor C testing, manufacturers can ensure patient safety, safeguard ecosystems, and embrace the next generation of sustainable endotoxin detection.